PREOPERATIVE HYPOFRACTIONED RADIOTHERAPY IN LOCALIZED EXTREMITY/TRUNK WALL SOFT TISSUE SARCOMAS EARLY STUDY RESULTS Hanna Kosela; Milena Kolodziejczyk;

Slides:



Advertisements
Similar presentations
Post-operative Radiotherapy for Esophageal Cancer Parag Sanghvi, M.D., M.S.P.H. Department of Radiation Medicine Esophageal Care Conference 3/26/2007.
Advertisements

CARBON ION THERAPY FOR SACRAL CHORDOMAS
Evaluation of Femur Fracture Risk in Soft-Tissue Sarcoma of the Thigh Treated with Intensity- Modulated Radiation Therapy (IMRT) Michael R. Folkert, MD.
Controversies in Adjuvant Therapy for Pancreatic Cancer Parag Sanghvi M.D. Tasha McDonald M.D. Department of Radiation Medicine OHSU.
Janet Eary 1, Janet O'Sullivan 3, Finbarr O'Sullivan 3, E. U. Conrad 2 1. Nuclear Medicine/Radiology, University of Washington, Seattle, WA, United States.
IMRT vs. BRACHYTHERAPY FOR SOFT TISSUE SARCOMA. EXTERNAL RT IN STS NCI Trial (Yang JC et al, JCO 1998) Extremity / Superficial Trunk STS (n=141) LSS Alone.
Postoperative Radiation for Oral Cavity Squamous Cell Carcinoma: The EP.
CO-I KNTM/K i CzS M. Sklodowska-Curie Memorial Cancer Center-Institute of Oncology Medical University of Warsaw; Warsaw, POLAND Medical University of Gdansk;
Synovial sarcoma- which patients don’t need adjuvant treatment? Khan M, Rankin KS, Beckingsale TB, Todd R, Gerrand CH North of England Bone and Soft Tissue.
Neoadjuvant Adjuvant Curative Palliative Neoadjuvant Radiation therapy the results of a phase III study from Beijing demonstrated a survival benefit.
Outcome Following Limb Salvage Surgery and External Beam Radiotherapy for High Grade Soft Tissue Sarcomas of the Groin and Axilla Rapin Phimolsarnti M.D.
Intra-Operative Radiation Therapy for Treatment of Early Stage Breast Cancer: Short Term Results from a Single Institution Clinical Trial Using Electronic.
Hypofractionated Radiation Therapy for Early Stage Breast Cancer Patrick J. Gagnon, M.D. Resident, PGY-4 Radiation Medicine, OHSU Providence Hospital Breast.
Time, Dose, and Fractionation
IMRT for the Treatment of Anal Cancer Kristen O’Donnell, MS3 December 12, 2007.
A phase I study on the combination of neoadjuvant radiotherapy plus pazopanib in patients with locally advanced soft tissue sarcoma of the extremities.
Birga Terlunen-Traboldt ENT-Journal Club Need for Neck dissection after Radiochemotherapy? A study of the French GETTEC Group Vedrine P;Thariat J;Hitier.
Sequential vs. concurrent chemoradiotherapy for locally advanced non-small cell carcinoma.
Intergroup trial CALGB 80101
A Phase II Study to Evaluate the Safety and Toxicity of Sparing Radiation to the Pathologic N0 Side of the Neck in Squamous Cell.
Long-term follow-up of a prospective trial of pre-operative external-beam radiation and post-operative brachytherapy for retroperitoneal sarcoma LA Mikula,
Phase II Presurgical Feasibility Study of Bevacizumab in Untreated Patients with Metastatic Renal Cell Carcinoma Jonasch E et al. Journal of Clinical Oncology.
Quantitative Dosimetric Analysis Of Patterns Of Local Relapse After IMRT For Primary Extremity Soft Tissue Sarcomas Ryan M. Lanning, Sean L. Berry, Michael.
An Assessment of Factors Affecting Outcome in Patients Presenting with Metastatic Soft Tissue Sarcoma Peter Ferguson MD1,2, Benjamin Deheshi MD1,2, Anthony.
Targeted Intraoperative Radiotherapy versus Whole Breast Radiotherapy for Breast Cancer (TARGIT-A Trial): An International, Prospective, Randomised, Non-Inferiority.
Adductor Compartment STS - Does method of treatment affect outcome? Anup Pradhan, Yiu-Chung Cheung Birmingham Medical School, UK Supervisors: Mr Robert.
HCI Sarcoma Services Sequential Dependency of Radiotherapy for Soft-Tissue Sarcoma S Sampath TE Schultheiss YJ Hitchcock RL Randall DC Shrieve JYC Wong.
Quantifying the Morbidity of the Unplanned Sarcoma Excision
Delivering clinical research to make patients, and the NHS, better OG neoadjuvant therapy Brachytherapy Stephen Falk dd/mm/yyyy.
Irradiation of stem cell niches in the periventricular and sub granular zones in gbm : A Prospective study Akram K S, Monica I, Deepa J, Kesava R, Fayaz.
Five year results of a randomized Phase III trial of pre-operative vs post-operative radiotherapy in extremity soft tissue sarcoma Brian O'Sullivan, Aileen.
EARLY PROGRESSION IN PATIENTS WITH HIGH-RISK SOFT TISSUE SARCOMAS AN ANALYSIS FROM A PHASE III RANDOMIZED PROSPECTIVE TRIAL (EORTC 62961/ESHO) OF NEOADJUVANT.
Per-Ulf Tunn, D. Andreou, S. Fehlberg, M. Werner, P. Reichardt
Jens Jakob 1 ; Anna Simeonova 2 ; Bernd Kasper 3 ; Ulrich Ronellenfitsch 1 ; Frederik Wenz 2 ; Peter Hohenberger 1 1 Department of Surgery, 2 Department.
CTOS, Berlin 2014 The influence of time interval between preoperative radiation and surgical resection on the development of wound healing complications.
Extra-Abdominal Fibromatosis : The Birmingham Experience
Effectiveness of Radiotherapy in Myxoid Sarcomas is Associated with a Dense Vascular Pattern Ronald de Vreeze, research physician Daphne de Jong Fiona.
Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC randomised trial From.
Radiation Therapy Connective Tissue Oncology Society 2005 Thomas F. DeLaney, M.D.
14 th Annual Meeting of the Connective Tissue Oncology Society November 13-15, 2008, London, UK Oliver Zivanovic, Mario M. Leitao, Alexia Iasonos, Lindsay.
The Influence of Age on Morbidity in Primary High Grade Sarcoma of the Extremity K. Alektiar, M. Brennan, S. Singer Memorial Sloan-Kettering Cancer Center.
Role of Sentinel Lymph Node Biopsy in the Staging of Synovial, Epithelioid, and Clear Cell Sarcomas. Ugwuji N. Maduekwe, Francis J. Hornicek, Dempsey S.
Dr Mark Saunders Christie Hospital and Paterson Institute of Cancer Research “ Rectal cancer radiotherapy – why do we give it and how do we do it?”
M ETHODS Median dose was 22Gy (range: ) in 1 to 5 fractions Median treatment volume was 12.6 cc (range: ). Assessed for eligibility.
Journal Club Dr. Eyad Al-Saeed Radiation Oncology 12 January, 2008.
Identification of localized rectal cancer (RC) patients (pts) who may NOT require preoperative (preop) chemoradiation (CRT). D. Roda 1, M. Frasson 2, E.
Carboplatin Not Inferior to Radiation as Adjuvant Therapy for Stage I Seminoma Slideset on: Oliver RT, Mason MD, Mead GM, et al. Radiotherapy versus single-dose.
SARC018: A SARC PILOT MULTICENTER STUDY OF PREOPERATIVE RADIATION AND SURGERY IN PATIENTS WITH HIGH- RISK DESMOID TUMORS Robert S. Benjamin, M.D.
What Factors Predict Outcome At Relapse After Previous Esophagectomy And Adjuvant Therapy in High-Risk Esophageal Cancer? Edward Yu 1, Patricia Tai 5,
Complete pathologic responses in the primary of rectal or colon cancer treated with FOLFOX without radiation A. Cercek, M. R. Weiser, K. A. Goodman, D.
Department of Clinical Radiotherapy, Royal Marsden Hospital, Sutton, Surrey SM2 5PT, UK R4 한재준 1.
Addition of Chemotherapy to Preoperative Radiotherapy Improves Outcomes in Rectal Cancer Slideset on: Bosset JF, Calais G, Mineur L, et al. Enhanced tumorocidal.
PHASE II TRIAL OF HYPOFRACTIONATED BREAST IRRADIATION WITH VMAT-SIB TECHNIQUE: TOXICITY AND EARLY CLINICAL ASSESSMENT IN 270 PATIENTS F. De Rose¹, F. Alongi¹,
방사선종양학과 - 혈액종양내과 Joint Conference 경희의료원 방사선종양학과 R4 공 문 규.
Rate of wound healing complications in patients with sarcoma excision and flap reconstruction. Mr. Paul Wilson. Mohamed Maklad.
Emily Tanzler, MD Waseet Vance, MD
Results of Definitive Radiotherapy in Anal Canal Carcinoma
Hypofractionated radiotherapy for breast cancer
Stage I Non Small Cell Lung Cancer (NSCLC): single centre comparison of outcome by treatment with surgery, conventional radiotherapy and stereotactic ablative.
นายแพทย์ธราธร ตุงคะสมิต นายแพทย์ชำนาญการพิเศษ โรงพยาบาลมะเร็งอุดรธานี
Treatment With Continuous, Hyperfractionated, Accelerated Radiotherapy (CHART) For Non-Small Cell Lung Cancer (NSCLC): The Weston Park Hospital Experience.
IMRT delivery of preoperative, high dose radiotherapy to a large volume, with Simultaneous Integrated Boost (SIB) in retroperitoneal sarcomas: The Ottawa.
Adjuvant Radiation is Required for Gastric Cancer
Radiation Therapy for Prostate Cancer
Authors: Nahhas, Mohammed, and Isler, Marc
Neoadjuvant Adjuvant Curative Palliative
Proton Therapy for Thymic Malignancies: Multi-institutional Patterns-of-Care and Early Clinical Outcomes from the Proton Collaborative Group Registry &
Presentation transcript:

PREOPERATIVE HYPOFRACTIONED RADIOTHERAPY IN LOCALIZED EXTREMITY/TRUNK WALL SOFT TISSUE SARCOMAS EARLY STUDY RESULTS Hanna Kosela; Milena Kolodziejczyk; Tadeusz Morysinski; Wirginiusz Dziewirski; Marcin Zdzienicki; Piotr Rutkowski Department of Soft Tissue/Bone Sarcoma and Melanoma, Department of Radiotherapy Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology Warsaw, Poland

Background  Primary treatment of majority of localized soft tissue sarcoma is surgical resection of the tumor with adequate margins combined with radiotherapy  Using radiotherapy in the local setting increases local control of the disease (with suggested survival benefit for patients with high grade tumors * ) * Koshy M, et al.. Improved survival with radiation therapy in high-grade soft tissue sarcomas of the extremities: a SEER analysis. Int J Radiat Oncol Biol Phys May 1;77(1):203-9

Background – preoperative radiotherapy vs postoperative setting No differences in local recurrence rate, regional and distant failure rates*; *O'Sullivan B, et al.. Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial.2002 Jun 29;359(9325): BenefitsDrawbacks Lower doses and smaller treatment field size; Possible improvement in tumor resectability; Smaller incidence in long term radiation- related complications; Increased risk of wound complications;

Background Can we shorten the overall treatment time by using hypofractionated radiotherapy and immediate surgery in STS as in rectal carcinoma? Potential benefits Lower risk of tumor clonogens repopulation Convenience Lower cost Radiobiological rationale: low α/β ratio: -0,5-5 Gy* *Gunderson LL, Tepper JE. Clinical Radiation Oncology. London, UK: Churchill Livingstone; 2007 *

AIM OF THIS PILOT STUDY Incidence of late complicatons and local recurrences compared to those observed after conventionally fractionated preoperative radiotherapy. Overall survival;

Patients and methods In the years , 262 patients received 5x5 Gy according to uniform internal preoperative protocol and underwent tumor resection within a consecutive week. In our analysis we included only patients with diagnosis of localized, resectable soft tissue sarcoma of the extremities or trunk wall (confirmed pathologically): primary or recurrent; deep seated and/or intermediate/high grade

Patients and methods 225 patients 122 (54%) women, 103 (46%) men Median age 54 years (range 18-82) Median follow up 34 months (range 1-80) Bioethical committee approval

Patients and methods  140 patients (62.2%)- primary tumors 75 patients (33%) – clinical local recurrence after previous surgery in another center 10 patients (4.4%)- after non-radical surgery in another center, but without clinical recurrence (scar)  56 (24.9%) patients received preoperative chemotherapy 75% of these patients had high grade tumors (G3)

Patients and methods

Synovial sarcoma

Patients and methods * 16 patients had also postoperative radiotherapy Tumor sizeMedian size 9cm (range 0,5-41cm) 45%>10cm Tumor grade29- G1 54-G G3 (60%) 6- unknown Final resection margin176- R0 (78%) 41- R1* 2-R2

Results 51 (22.6%) patients were dead at the time of analysis 93 (41.3%) recurrences of the disease 46 - local recurrence (20% local recurrence = 80% local control rate) - in 10 patients after local recurrence amputation was performed 78 (34.7%)- distant metastases 31 (13.8%) patients had local and distant recurrence of the disease

~70%

~80%

Factors influencing survival (univariate analysis) OS: -Tumor size (p = 0.05) -Tumor grade (p = ) LRFS: - Tumor grade (p = 0.007)

p=0.05

`~80% ~~60%

~75% ~~57%

Complications of the treatment 97 patients (43%) had postoperative wound complications including 9 patients (4%) who required an additional surgical procedure 33.6% of patients with complications received preoperative chemotherapy 87 patients with wound complications (89.6%) had tumor localized on the lower limb

Early local complications 38 (16.9%) patients had prolonged healing of the wound (>1 month) 28 (12.4%) patients had wound dehiscence 9 (4%) patients required prolonged punctures of the collecting lymph fluid 6 (2.7%) patients had an increased acute skin toxicity

Late complications 2 (0.8%) patients severe fibrosis leading to contracture of the limb 24 (10.7%) patients prolonged edema of the operated limb 6 (2.7%) patients - fracture of the treated limb (median time from treatment to fracture 18 months)

Discussion

Conclusions Local control rates an overall survival similar to those seen in patients treated with preoperative radiotherapy conventionally fractionated; Our series comprises majority of high risk patients with large high grade tumors; Wound complication - quite high rate of early complications but low percentage of severe complications; Late complications - similar to those seen in patients treated with preoperative radiotherapy conventionally fractionated

Clinical trial? „Short-course” preoperative radiotherapy vs conventional radiotherapy

Cancer Center – Institute; Warsaw: K. Wiater, S. Falkowski, A. Klimczak, T. Świtaj, K. Ptaszyński, U. Grzesiakowska, E. Bylina, A, Głuszcz,… Our patients and their families ACKNOWLEDGEMENTS

Thank you for your attention! Cancer Center, Warsaw, Poland